Long-term results of [18F] Fluorocholine PET/CT guided SBRT in patients with prostate cancer

被引：0
|
作者：
Pasqualetti, F. [1 ]
Panichi, M. [2 ]
Cocuzza, P. [3 ]
Gonnelli, A. [3 ]
Baldaccini, D. [3 ]
Molinari, A. [3 ]
Cantarella, M. [4 ]
Mattioni, R. [3 ]
Montrone, S. [2 ]
Cristaudo, A. [3 ]
Marciano, A. [5 ]
Zanca, R. [5 ]
Sollini, M. [6 ]
Sainato, A. [2 ]
Erba, P. A. [5 ]
Paiar, F. [3 ]
机构：
[1] Azienda Osped Univ Pisana, Oncol, Pisa, Italy
[2] Azienda Osped Univ Pisana, Radiotherapy, Pisa, Italy
[3] Univ Pisa, Radiotherapy, Pisa, Italy
[4] Casa Cura Sanrossore, Radiotherapy, Pisa, Italy
[5] Univ Pisa, Nucl Med, Pisa, Italy
[6] Humanitas Canc Ctr, Nucl Med, Milan, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)31988-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1568
引用
收藏
页码：S847 / S847
页数：1
相关论文
共 50 条
  • [31] Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading
    Langsteger, W.
    Balogova, S.
    Huchet, V.
    Beheshti, M.
    Paycha, F.
    Egrot, C.
    Janetschek, G.
    Loidl, W.
    Nataf, V.
    Kerrou, K.
    Pascal, O.
    Cussenot, O.
    Talbot, J. -N.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 55 (04): : 448 - 457
  • [32] BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study)
    Mohsen Beheshti
    Thomas Kunit
    Silke Haim
    Rasoul Zakavi
    Christian Schiller
    Andrew Stephens
    Ludger Dinkelborg
    Werner Langsteger
    Wolfgang Loidl
    Molecular Imaging and Biology, 2015, 17 : 424 - 433
  • [33] BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study)
    Beheshti, Mohsen
    Kunit, Thomas
    Haim, Silke
    Zakavi, Rasoul
    Schiller, Christian
    Stephens, Andrew
    Dinkelborg, Ludger
    Langsteger, Werner
    Loidl, Wolfgang
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (03) : 424 - 433
  • [34] Effect of androgen deprivation therapy on the results of PET/CT with [18F]fluciclovine in patients with prostate cancer
    Bach-Gansmo, T.
    Sletten, H.
    Smastuen, M. C.
    Londalen, A. M.
    Bogsrud, T. V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S123 - S123
  • [35] Incidental detection of breast cancer on [18F] fluorocholine PET/CT: a retrospective analysis
    Androjna, A.
    Hocevar, M.
    Rep, S.
    Zaletel, K.
    Lezaic, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S477 - S477
  • [36] [18F]DCFPyL PET/CT for Imaging of Prostate Cancer
    Rowe, Steven P.
    Buck, Andreas
    Bundschuh, Ralph A.
    Lapa, Constantin
    Serfling, Sebastian E.
    Derlin, Thorsten
    Higuchi, Takahiro
    Gorin, Michael A.
    Pomper, Martin G.
    Werner, Rudolf A.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022, 61 (03): : 240 - 246
  • [37] Role of [18F]Choline PET/CT guided stereotactic body radiotherapy in patients with oligometastatic prostate cancer
    Boni, R.
    Marciano, A.
    Zanca, R.
    Sollini, M.
    Notini, E.
    Baldaccini, D.
    Matteucci, F.
    Cocuzza, P.
    Ferrazza, P.
    Coraggio, G.
    Paiar, F.
    Pasqualetti, G.
    Galli, L.
    Mannelli, L.
    Pasqualetti, F.
    Erba, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S720 - S721
  • [38] [18F]fluorocholine PET/CT: local functional-pathological correlation and whole-body distribution in patients with prostate cancer
    Schmid, DT
    John, H
    Zweifel, R
    Goerres, GW
    Husarik, D
    Cservenyak, T
    Westera, G
    von Schulthess, GK
    Hany, TF
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S252 - S253
  • [39] Timing for 18F-Fluorocholine PET/CT acquisition in patients with metastatic prostate cancer.
    Cimitan, M.
    Borsatti, E.
    Tatta, R.
    Drigo, A.
    Rampin, L.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S160 - S160
  • [40] Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients
    Rager, O.
    Baskin, A.
    Amzalag, G.
    Buchegger, F.
    Miralbell, R.
    Ratib, O.
    Zilli, T.
    Garibotto, V.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (05): : 211 - 216
12345